benzyl 3-butenoate | 86170-45-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: benzyl 3-butenoate
• 英文别名: benzyl but-3-enoate；3-Butenoic acid, phenylmethyl ester
• CAS: 86170-45-8
• 化学式: C₁₁H₁₂O₂
• mdl: MFCD27930272
• 分子量: 176.215
• InChiKey: DIHWNRNXRGICRQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.181
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 储存条件：
  2-8℃

反应信息

• 作为反应物：
  描述：

  benzyl 3-butenoate 在 sodium hydroxide 、 2-甲基-2-丁烯 、 硼烷 、 双氧水 作用下， 生成 4-羟基丁酸苄酯
  参考文献：
  名称：

  Renin inhibitory peptides. Incorporation of polar, hydrophilic end groups into an active renin inhibitory peptide template and their evaluation in a human renin-infused rat model and in conscious sodium-depleted monkeys

  摘要：

  We previously reported that Boc-Pro-Phe-N-MeHis-Leu-psi[CHOHCH2]?? -Ile-Amp (1) is a potent and specific inhibitor of human renin in vitro. It was shown to resist degradation by selected proteases and a rat liver homogenate. It was shown to inhibit plasma renin activity and to reduce blood pressure in renin-dependent-animal models both by the intravenous and by the oral routes using dilute citric acid as vehicle. In an effort to discover compounds with improved pharmacological efficacy, we set out to modify the physical characteristics of this highly lipophilic renin inhibitor by incorporation of hydrophilic end groups. We report here a variety of water-solubilizing groups and the resulting structure-activity relationship of these compounds. They all maintain an extremely high level of enzyme inhibitory activity in vitro. Evaluation of these potent renin inhibitors in a human renin infused rat model suggests that some of these compounds exhibit improved pharmacological efficacy in vivo. This observation was further confirmed in the conscious sodium-depleted cynomolgus monkey. Importantly, the oral efficacy was demonstrated in a water vehicle in the absence of citric acid.

  DOI：

  10.1021/jm00106a026
• 作为产物：
  描述：

  (2S)-2-氨基-5-(苄氧基)-5-氧代戊酸 在 吖啶 、 chloropyridinecobaloxime(III) 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 反应 36.0h， 以72%的产率得到benzyl 3-butenoate
  参考文献：
  名称：

  羧酸和生物质的光催化化学酶相容脱氢脱羧合成烯烃

  摘要：

  通过温和的化学选择性催化方法将可再生生物质和生物衍生化学品直接转化为有价值的合成中间体，用于有机合成和材料科学应用，在很大程度上仍然难以捉摸。通过利用以前无法实现的反应性和选择性模式，开发与酶促反应兼容的人工催化系统为这一持久挑战提供了协同解决方案。我们在此报告了一种双催化脱氢脱羧反应，该反应是通过光诱导吖啶催化的 O-H 氢原子转移 (HAT) 和钴肟催化的 C-H-HAT 过程的交叉实现的。该反应由容易获得的羧酸产生多种烯烃。

  DOI：

  10.1021/acscatal.9b02951

文献信息

• Cyclic Peptide-Polymer Complexes and Their Self-Assembly
  作者：Dominique Bélanger、Xia Tong、Sadia Soumaré、Yves L. Dory、Yue Zhao

  DOI：10.1002/chem.200802337

  日期：2009.4.20

  Pepped up polymers: The synthesis and properties of novel chiral cyclic peptides designed to complex with suitable polymers through hydrogen bonding are described. A substituted cyclic peptide self‐assembles into supramolecular nanotubes and develops noncovalent interactions with poly(vinyl alcohol) (PVA) by means of its carboxyl side chains.

  切碎的聚合物：描述了旨在通过氢键与合适的聚合物络合的新型手性环肽的合成和性质。取代的环肽会自组装成超分子纳米管，并通过其羧基侧链与聚乙烯醇（PVA）发生非共价相互作用。
• SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME
  申请人：BlinkBio, Inc.

  公开号：US20170202970A1

  公开（公告）日：2017-07-20

  Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.

  本文描述了基于硅的共轭物，能够将一个或多个有效载荷基团传递到靶细胞或组织。考虑到的共轭物可能包括一个硅-杂原子核心，一个或多个可选的催化基团，一个定位基团，允许共轭物在靶细胞或组织内积累，一个或多个有效载荷基团（例如，治疗剂或成像剂），以及与硅-杂原子核心共价结合的两个或更多个不干扰基团。
• Asymmetric Synthesis of α,β-Unsaturated δ-Lactones through Copper(I)-Catalyzed Direct Vinylogous Aldol Reaction
  作者：Hai-Jun Zhang、Liang Yin

  DOI：10.1021/jacs.8b07929

  日期：2018.9.26

  for the asymmetric synthesis of chiral α,β-unsaturated δ-lactones was achieved by copper(I)-catalyzed direct vinylogous aldol reaction (DVAR) of β,γ-unsaturated esters and various aldehydes, including aromatic aldehydes, heteroaromatic aldehydes, α,β-unsaturated aldehydes, and aliphatic aldehydes. For aromatic and heteroaromatic aldehydes, a one-pot reaction consisting of DVAR, isomerization of the

  通过铜（I）催化的 β,γ-不饱和酯和各种醛（包括芳香醛、杂芳香醛）的直接乙烯基醛醇反应 (DVAR)，实现了一种不对称合成手性 α,β-不饱和 δ-内酯的简单方法、α,β-不饱和醛和脂肪醛。对于芳香醛和杂芳香醛，需要由 DVAR、不饱和碳-碳双键从 (E)-形式异构化为 (Z)-形式以及随后的分子内酯交换组成的一锅反应，以获得中等至高产率和高对映选择性。对于 α,β-不饱和醛和脂肪族醛，DVAR 直接以中等收率和高对映选择性提供内酯。在 DVAR 中，各种功能组都具有良好的耐受性。而且，该方法很好地适用于分布在天然产物、天然产物衍生物和药物分子衍生物（托莫西汀和萘普生）中的醛基。机理研究表明，α-加成是可逆的且不受青睐，这说明了 DVAR 具有出色的区域选择性。提出通过去质子化产生的铜 (I)-二烯醇化物物质与烯丙基铜 (I) 物质形成平衡，烯丙基铜 (I) 物质与醛反应通过醛的催化不对称烯丙基化提供
• [EN] ARYLAMIDES AND METHODS OF USE THEREOF<br/>[FR] ARYLAMIDES ET LEURS PROCÉDÉS D'UTILISATION
  申请人：GENZYME CORP

  公开号：WO2021113809A1

  公开（公告）日：2021-06-10

  The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.

  本公开涉及杂环化合物，其药用盐以及药物制剂。本文还描述了这些化合物的组成以及在治疗由CFTR活性不足介导的疾病和病况的方法中的使用，特别是囊性纤维化。
• SO₂F₂-Mediated Epoxidation of Olefins with Hydrogen Peroxide
  作者：Chengmei Ai、Fuyuan Zhu、Yanmei Wang、Zhaohua Yan、Sen Lin

  DOI：10.1021/acs.joc.9b01784

  日期：2019.9.20

  An inexpensive, mild, and highly efficient epoxidation protocol has been developed involving bubbling SO2F2 gas into a solution of olefin, 30% aqueous hydrogen peroxide, and 4 N aqueous potassium carbonate in 1,4-dioxane at room temperature for 1 h with the formation of the corresponding epoxides in good to excellent yields. The novel SO2F2/H2O2/K2CO3 epoxidizing system is suitable to a variety of

  已开发出一种廉价，温和且高效的环氧化方案，包括在室温下将SO2F2气体鼓泡到烯烃，30％过氧化氢水溶液和4 N碳酸钾水溶液在1,4-二恶烷中的溶液中1h相应的环氧化物的收率好至极好。新型的SO2F2 / H2O2 / K2CO3环氧化系统适用于各种烯属底物，包括富电子和电子不足的底物。